CIK 0001806952 · Non-accelerated filer<br>Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 833006753
- Phone
- 650 695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Scientific Officer sold 129 shares at $15.93 ($2,055)
- 4 Open-market sale Chief Operating Officer sold 88 shares at $15.93 ($1,402)
- 4 Open-market sale President and CEO sold 545 shares at $15.93 ($8,682)
- 4 Open-market sale VP, Corporate Controller sold 416 shares at $15.93 ($6,627)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 1 of 9 · 173 filings